Home/Filings/4/0001209191-20-049301
4//SEC Filing

Chaubey Alka 4

Accession 0001209191-20-049301

CIK 0001411690other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 12:43 PM ET

Size

5.8 KB

Accession

0001209191-20-049301

Insider Transaction Report

Form 4
Period: 2020-09-01
Chaubey Alka
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-09-01+300,000300,000 total
    Exercise: $0.56Exp: 2030-09-01Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on August 31, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such applicable vesting date and the terms of the Issuer's 2020 Inducement Plan.

Issuer

Bionano Genomics, Inc

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001821605

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 12:43 PM ET
Size
5.8 KB